A high-throughput screening identifies MCM chromatin loading inhibitors targeting cells with increased replication origins
Lucia Falbo,
Hervé Técher,
Vincenzo Sannino,
Michela Robusto,
Giovanni Fagà,
Federica Pezzimenti,
Francesco Romeo,
Luca Gabriele Colombo,
Stefania Vultaggio,
Daniele Fancelli,
Silvia Monzani,
Valentina Cecatiello,
Sebastiano Pasqualato,
Mario Varasi,
Ciro Mercurio,
Vincenzo Costanzo
Affiliations
Lucia Falbo
IFOM-ETS, The AIRC Institute of Molecular Oncology, Milan, Italy; Department of Oncology and Hematology-Oncology, University of Milan, 20133 Milan, Italy
Hervé Técher
IFOM-ETS, The AIRC Institute of Molecular Oncology, Milan, Italy
Vincenzo Sannino
IFOM-ETS, The AIRC Institute of Molecular Oncology, Milan, Italy
Michela Robusto
IFOM-ETS, The AIRC Institute of Molecular Oncology, Milan, Italy
Giovanni Fagà
IFOM-ETS, The AIRC Institute of Molecular Oncology, Milan, Italy
Federica Pezzimenti
IFOM-ETS, The AIRC Institute of Molecular Oncology, Milan, Italy
Francesco Romeo
IFOM-ETS, The AIRC Institute of Molecular Oncology, Milan, Italy; Department of Oncology and Hematology-Oncology, University of Milan, 20133 Milan, Italy
Luca Gabriele Colombo
IFOM-ETS, The AIRC Institute of Molecular Oncology, Milan, Italy
Stefania Vultaggio
IFOM-ETS, The AIRC Institute of Molecular Oncology, Milan, Italy
Daniele Fancelli
IFOM-ETS, The AIRC Institute of Molecular Oncology, Milan, Italy
Silvia Monzani
Department of Experimental Oncology, European Institute of Oncology (IEO) IRCCS, 20141 Milan, Italy
Valentina Cecatiello
Department of Experimental Oncology, European Institute of Oncology (IEO) IRCCS, 20141 Milan, Italy
Sebastiano Pasqualato
Department of Experimental Oncology, European Institute of Oncology (IEO) IRCCS, 20141 Milan, Italy
Mario Varasi
IFOM-ETS, The AIRC Institute of Molecular Oncology, Milan, Italy
Ciro Mercurio
IFOM-ETS, The AIRC Institute of Molecular Oncology, Milan, Italy; Corresponding author
Vincenzo Costanzo
IFOM-ETS, The AIRC Institute of Molecular Oncology, Milan, Italy; Department of Oncology and Hematology-Oncology, University of Milan, 20133 Milan, Italy; Corresponding author
Summary: Replication origin assembly is a pivotal step in chromosomal DNA replication. In this process, the ORC complex binds DNA and, together with the CDC6 and CDT1, promotes the loading of the MCM helicase. Chemicals targeting origin assembly might be useful to sensitize highly proliferative cancer cells. However, identifying such compounds is challenging due to the multistage nature of this process. Here, using Xenopus laevis egg extract we set up a high-throughput screening to isolate MCM chromatin loading inhibitors, which led to the identification of NSC-95397 as a powerful inhibitor of replication origin assembly that targets CDC6 protein and promotes its degradation. Using systems developed to test selective drug-induced lethality we show that NSC-95397 triggers cell death both in human cells and Xenopus embryos that have higher proliferative ability. These findings demonstrate the effectiveness of molecules disrupting DNA replication processes in targeting hyperproliferating cells, highlighting their potential as anti-cancer molecules.